SCHEMBL14770593

SCHEMBL14770593

c1cc(-c2ccc3oc4ccccc4c3c2)nc(-c2ccc3oc4ccc(-c5cncc(-n6c7ccccc7c7ccccc76)c5)cc4c3c2)c1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CASP3 P42574 1/20 0.34
SENP7 Q9BQF6 1/20 0.34
SENP6 Q9GZR1 1/20 0.34
CHEK2 O96017 1/20 0.34
PDE10A Q9Y233 4/20 0.34
KDM4E B2RXH2 2/20 0.33
NPC1 O15118 2/20 0.33
MAPT P10636 2/20 0.33
MEN1 O00255 1/20 0.33
ALDH1A1 P00352 1/20 0.33
HPGD P15428 1/20 0.33
RAB9A P51151 1/20 0.33
KMT2A Q03164 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
PLA2G2A P14555 2/20 0.32
PLA2G4A P47712 2/20 0.32
PLA2G10 O15496 1/20 0.32
ATM Q13315 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31
PGR P06401 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14770591 0.91 IRAK4 (0.32) CASP3SENP7SENP6KDM4EPLA2G2A
SCHEMBL14770602 0.91 PLA2G2A (0.39) CASP3SENP7SENP6CHEK2PDE10A
SCHEMBL14770592 0.87 KDM4E (0.38) KDM4ENPC1MAPTMEN1ALDH1A1
SCHEMBL14770600 0.87 CYP19A1 (0.37) CHEK2KDM4EMAPTALDH1A1HPGD
SCHEMBL14770554 0.86 KDM4E (0.36) CASP3SENP7SENP6CHEK2PDE10A
SCHEMBL14770569 0.86 KDM4E (0.38) CASP3SENP7SENP6CHEK2KDM4E
SCHEMBL20706811 0.85 KDM4E (0.43) CASP3SENP7SENP6CHEK2KDM4E
SCHEMBL14770636 0.84 CASP3 (0.36) CASP3SENP7SENP6CHEK2KDM4E
SCHEMBL20706734 0.84 KDM4E (0.44) CASP3SENP7SENP6CHEK2KDM4E
SCHEMBL14770667 0.84 PLA2G2A (0.39) CASP3SENP7SENP6CHEK2PDE10A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9604972-B2 Nitrogen-containing heteroaromatic ring compound IDEMITSU KOSAN CO., LTD. (JP) 2017-03-28 US disclosed
US-9604972-B2 Nitrogen-containing heteroaromatic ring compound IDEMITSU KOSAN CO., LTD. (JP) 2017-03-28 US disclosed
US-20130062597-A1 NITROGEN-CONTAINING HETEROAROMATIC RING COMPOUND IDEMITSU KOSAN CO., LTD. (JP) 2013-03-14 US disclosed
US-20130062597-A1 NITROGEN-CONTAINING HETEROAROMATIC RING COMPOUND IDEMITSU KOSAN CO., LTD. (JP) 2013-03-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130062597-A1 NITROGEN-CONTAINING HETEROAROMATIC RING COMPOUND TDO2, AHR, NOC2L CASP3 2891/4885SENP7 4417/4885SENP6 4592/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.